Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Mission Includes Clearer Efficacy Guidance – Vanderbilt’s Wood

This article was originally published in The Tan Sheet

Executive Summary

FDA's focus on post-marketing safety should be accompanied by clearer clinical efficacy standards, Vanderbilt Assistant Vice Chancellor Alastair Wood, MD, suggested during a March 6 hearing on user fees

You may also be interested in...



Bush Seeking New FDA Commissioner Candidates With Wood Cut From List

The Bush Administration once again is seeking names of potential FDA commissioner candidates

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS093724

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel